Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation.

× No keyword cloud information.

19 in total

1. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors: A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal: Proc Natl Acad Sci U S A Date: 2000-11-21 Impact factor: 11.205

Review 2. Can persistent IgE responses be suppressed?

Authors: D M Kemeny; D Diaz-Sanchez
Journal: Clin Exp Immunol Date: 1990-12 Impact factor: 4.330

3. Recombinant soluble form of the human high-affinity immunoglobulin E (IgE) receptor inhibits IgE production through its specific binding to IgE-bearing B cells.

Authors: Y Yanagihara; K Kajiwara; K Ikizawa; T Koshio; K Okumura; C Ra
Journal: J Clin Invest Date: 1994-11 Impact factor: 14.808

Review 4. Plasma cells as an innovative target in autoimmune disease with renal manifestations.

Authors: Falk Hiepe; Andreas Radbruch
Journal: Nat Rev Nephrol Date: 2016-02-29 Impact factor: 28.314

5. Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression.

Authors: Xi Yang; Yijun Fan; Shuhe Wang; Xiaobing Han; Jie Yang; Laura Bilenki; Lijun Chen
Journal: Immunology Date: 2002-03 Impact factor: 7.397

6. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.

Authors: H N Willcox; J Newsom-Davis; L R Calder
Journal: Clin Exp Immunol Date: 1984-10 Impact factor: 4.330

7. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.

Authors: H N Willcox; J Newsom-Davis; L R Calder
Journal: Clin Exp Immunol Date: 1983-11 Impact factor: 4.330

8. In vitro synthesis of IgE by human peripheral blood leucocytes. III. Release of pre-formed antibody.

Authors: K J Turner; P G Holt; B J Holt; K J Cameron
Journal: Clin Exp Immunol Date: 1983-02 Impact factor: 4.330

9. Greatly improved recovery of in vitro B-memory cell function after enzymic dispersion of immunized mouse spleens.

Authors: A N Brown; H N Willcox
Journal: Immunology Date: 1991-12 Impact factor: 7.397

10. In vitro production of IgE by human peripheral blood mononuclear cells. IV. Modulation by allergen of the spontaneous IgE antibody biosynthesis.

Authors: S Romagnani; E Maggi; G F Del Prete; F Almerigogna; R Biagiotti; M G Giudizi; M Ricci
Journal: Clin Exp Immunol Date: 1982-07 Impact factor: 4.330